ARTICLE | Clinical News
Genervon preclinical data
January 14, 2013 8:00 AM UTC
In a mouse model of ALS with mutant superoxide dismutase 1 (SOD1), GM604 significantly improved clinical scores vs. vehicle-treated controls (p<0.001). GM604 also delayed time to onset of ALS symptom...